Big drug companies have little incentive to develop new antibiotics despite huge concerns about resistance to the drugs, according to a group of leading pharmacists.
The Royal Pharmaceutical Society (RPS) said the prospect of creating new drugs was "low due to the poor return on investment they provide".
The RPS said in its latest report that more must be done to support the discovery of new antibiotics.
It also called for the public to become more educated on the use of the medicines and better management of the drugs by healthcare workers.
More top news
Delivery firms hold out against calls to improve conditions for self-employed workers as Hermes says any such move could cause job losses.
Wet and very windy weather spread in from the west overnight with snow expected across much of southern Scotland.
Family of suicide bomber Jamal al Harith said he would never have turned to terror before he was held for two years in notorious US camp.